David Wynick, joint Research Director at North Bristol and University Hospitals Bristol NHS Trusts and Professor of Molecular Medicine at University of Bristol, has taken on the newly created role of chair of the Bristol Health Partners Executive Group. The role is designed to strengthen links between the Executive Group and the Board.
Chair of the Bristol Health Partners Board and Chief Executive of North Bristol Trust, Andrea Young said:
“The Board is working closely with the partnership’s Executive Group to make sure we’re using this group’s considerable talents to best advantage. Executive Group members are advocates for the partnership in their organisations and they help the core team implement the vision for the partnership. We want to augment this vital role. David Wynick, as chair of the Executive Group, will be pivotal in helping us realise the potential of the Executive Group.”
David Relph, Director of Bristol Health Partners, said:
“It's great news for the partnership that David has taken on this new role. I'm looking forward to working closely with David during what will be a key period for the partnership, as we look ahead and refresh the partnership agreement on which Bristol Health Partners is based. David, and the rest of the Executive Group, will be central to this process and I look forward to their contribution.”
David Wynick said:
“I am honoured to be asked to take on the role of chair and look forward to continuing the close and productive working relationship I have with the other members of the Bristol Health Partners Executive and the Director David Relph.”